Impact of Acid Suppression on Upper Gastrointestinal pH and Motility
- 497 Downloads
Proton pump inhibitors (PPIs), widely prescribed to patients with upper gastrointestinal symptoms, alter intragastric pH, and may affect upper gastrointestinal transit and motility parameters in addition to affecting the ability to determine Wireless Motility Capsule (WMC) gastric emptying time.
To assess PPI effect on motility parameters of the upper gastrointestinal tract and to determine if PPIs confound ability of WMC to measure gastric emptying time.
Twenty healthy subjects were treated with esomeprazole 40 mg bid for 1 week. Another 50 healthy subjects underwent evaluation in absence of PPIs. All subjects underwent WMC test after meal ingestion. After a rapid, sustained luminal pH rise ≥ 0.5 pH units, marking potential gastric emptying time of WMC, an abdominal X-ray (KUB) was taken for gastric emptying time confirmation. Mean pH, pressure and transit time were compared between PPI-treated and untreated groups.
There was no difference in gastric emptying time, small bowel transit time (SBTT), or pressure profiles between the groups. The pH in all cases rose ≥ 0.5 pH units. Distal small bowel pH was significantly lower in subjects on PPIs. Gastric emptying time was identified in all subjects treated with PPIs. Pressure and slope criteria were developed to confirm the time of emptying.
PPI therapy does not have a significant impact on upper gastrointestinal transit and motility but it does decrease distal small bowel pH. The medication reduced the magnitude of pH change at gastric emptying time but using additional criteria based on slope and contraction frequency, WMC was able to measure gastric emptying time in all patients treated with PPIs.
KeywordsStomach and duodenum Gastric emptying Motility Acidity (intragastric)
This study was funded in part by The Smart Pill Corporation, grant number 208598, also in part by the National Institute of Health, grant number 218969, and International Foundation for Functional Gastrointestinal Disorders.
- 2.Castell D, Bagin R, Goldlust B, Major J, Hepburn B. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;21(12):1467–1474.PubMedCrossRefGoogle Scholar
- 4.Kuo B, Viazis N, Bahadur S, et al. Non-invasive simultaneous measurement of intra-luminal pH and pressure: assessment of gastric emptying and upper GI manometry in healthy subjects. Neurogastroenterol Motil. 2004; 16:666, #61.Google Scholar
- 15.Shuster M, Crowell MD, Koch KL. Shuster atlas of gastrointestinal motility in health and disease. 2nd ed. Ontario: BC Decker Inc; 2002.Google Scholar
- 16.Zarate N, et al. Accurate localisation of a fall in pH within the ileo-caecal region: validation using a dual scintigraphic technique. Am J Physiol Gastrointest Liver Physiol. 2010 [Epub ahead of print].Google Scholar